Icon Plc (ICLR) Valuation
Historical valuation analysis based on 500 data points (2024-09-25 to 2026-09-23)
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical tr...
Icon Plc (ICLR) currently trades at a P/E ratio of 60.48 (historical range: 14.47–74.88, median: 27.94), placing it at the 85th percentile — expensive relative to its history, P/S ratio of 1.57 (range: 0.77–3.06, 36th percentile — below its historical average), EV/EBITDA of 36.39 (range: 12.96–43.61, 85th percentile).
Over the historical period (2024-09-25 to 2026-09-23), Icon Plc's P/E ratio has expanded by 88% over the observed period (from an average of 23.5 to 44.2).
Icon Plc trades above its historical valuation range, with most metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 60.48 | 14.47 | 27.94 | 74.88 | 85th | expensive relative to its history |
| P/S Ratio | 1.57 | 0.77 | 1.66 | 3.06 | 36th | below its historical average |
| EV/EBITDA | 36.39 | 12.96 | 20.03 | 43.61 | 85th | expensive relative to its history |
| FCF Yield | 0.08 | 0.05 | 0.08 | 0.16 | 63th | below its historical average |
Icon Plc (ICLR) Valuation & P/E History
Icon Plc (ICLR) is a US-listed stock operating in the Other sector currently trading at $163.90 with a market capitalization of $12.7 billion. This page provides historical valuation analysis for ICLR based on 500 data points covering 2024-09-25 to 2026-09-23. The P/E ratio of 60.48 is above the historical median of 27.94, placing ICLR at the 85th percentile of its valuation range. The P/S ratio of 1.57 compares to a median of 1.66.
ICLR Valuation Metrics & Historical Range
The valuation table above shows Icon Plc's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether ICLR is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests ICLR is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Icon Plc.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is ICLR Overvalued or Undervalued?
Icon Plc trades above its historical valuation range, with most metrics above their median levels. The overall valuation percentile of 69 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive ICLR is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full ICLR analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.ICLR trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.